Brind.

Viatris is involved in a development where Australia, New Zealand, and Japan are part of the JANZ segment.

1 report, 1 independent Updated Aug 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Mylan

How it developed

Newest first. Tap a step to see who reported it.

Jun 7Viatris was classified into the Zacks Medical Services industry as of August 7, 2025.Sub-event
Aug 7Australia, New Zealand, and Japan are part of the JANZ segment involving Viatris.1 source
- Zacks

Keep exploring

The entities involved

Mylan
former pharmaceutical company
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.Mon 11:01
- Zymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Mon 11:01

Coverage

Newest first; wire copies grouped

Aug 7ZacksViatris Stock Rises as Q2 Earnings & Revenues Beat Estimates Viatris Inc. (VTRS) delivered second-quarter 2025 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate of 56 c